HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 9.4 Linux 31MAR21:12:06:0931MAR21:12:06:09 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS TV SASDATA 9.4 Linux 31MAR21:12:06:0931MAR21:12:06:09 Trial Visits HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000000800000000000000000000 STUDYID Study Identifier DOMAIN Domain Abbreviation VISITNUMVisit Number VISIT Visit Name VISITDY Planned Study Day of Visit ' ARMCD Planned Arm Code />TVSTRL Visit Start Rule 8-TVENRL Visit End Rule vHEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 C4591001TVACOVID_A . COVID-19 illness onset End of COVID-19 illness visit 1 C4591001TVA COVID_B . COVID-19 illness onset End of COVID-19 illness visit 2 C4591001TVA0COVID_C . COVID-19 illness onset End of COVID-19 illness visit 3 C4591001TVA@COVID_D . COVID-19 illness onset End of COVID-19 illness visit 4 C4591001TVAPCOVID_E . COVID-19 illness onset End of COVID-19 illness visit 5 C4591001TVA`COVID_F . COVID-19 illness onset End of COVID-19 illness visit 6 C4591001TVApCOVID_G . COVID-19 illness onset End of COVID-19 illness visit 7 C4591001TVACOVID_H . COVID-19 illness onset End of COVID-19 illness visit 8 C4591001TVACOVID_I . COVID-19 illness onset End of COVID-19 illness visit 9 C4591001TVACOVID_J . COVID-19 illness onset End of COVID-19 illness visit 10 C4591001TVACOVID_K . COVID-19 illness onset End of COVID-19 illness visit 11 C4591001TVACOVID_L . COVID-19 illness onset End of COVID-19 illness visit 12 C4591001TVACOVID_M . COVID-19 illness onset End of COVID-19 illness visit 13 C4591001TVACOVID_N . COVID-19 illness onset End of COVID-19 illness visit 14 C4591001TVACOVID_O . COVID-19 illness onset End of COVID-19 illness visit 15 C4591001TVBCOVID_P . COVID-19 illness onset End of COVID-19 illness visit 16 C4591001TVBCOVID_Q . COVID-19 illness onset End of COVID-19 illness visit 17 C4591001TVBCOVID_R . COVID-19 illness onset End of COVID-19 illness visit 18 C4591001TVBCOVID_S . COVID-19 illness onset End of COVID-19 illness visit 19 C4591001TVBCOVID_T . COVID-19 illness onset End of COVID-19 illness visit 20 C4591001TVBCOVID_A1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 1 C4591001TVBCOVID_B1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 2 C4591001TVBCOVID_C1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 3 C4591001TVBCOVID_D1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 4 C4591001TVBCOVID_E1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 5 C4591001TVBCOVID_F1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 6 C4591001TVBCOVID_G1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 7 C4591001TVBCOVID_H1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 8 C4591001TVBCOVID_I1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 9 C4591001TVBCOVID_J1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 10C4591001TVBCOVID_K1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 11C4591001TVBCOVID_L1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 12C4591001TVBCOVID_M1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 13C4591001TVBCOVID_N1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 14C4591001TVBCOVID_O1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 15C4591001TVBCOVID_P1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 16C4591001TVBCOVID_Q1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 17C4591001TVBCOVID_R1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 18C4591001TVBCOVID_S1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 19C4591001TVBCOVID_T1 . After the visit of COVID-19 illness onset End of COVID-19 illness convalescent visit 20C4591001TVDNSSWAB_WEEK2 . Surveillance swab sample collection at week 2 End of visit assessment C4591001TVDNSSWAB_WEEK4 . Surveillance swab sample collection at week 4 End of visit assessment C4591001TVDNSSWAB_WEEK6 . Surveillance swab sample collection at week 6 End of visit assessment C4591001TVDNSSWAB_WEEK8 . Surveillance swab sample collection at week 8 End of visit assessment C4591001TVDNSSWAB_WEEK10 . Surveillance swab sample collection at week 10 End of visit assessment C4591001TVDNSSWAB_WEEK12 . Surveillance swab sample collection at week 12 End of visit assessment C4591001TVDNSSWAB_WEEK14 . Surveillance swab sample collection at week 14 End of visit assessment C4591001TVDNSSWAB_WEEK16 . Surveillance swab sample collection at week 16 End of visit assessment C4591001TVDNSSWAB_WEEK18 . Surveillance swab sample collection at week 18 End of visit assessment C4591001TVDNSSWAB_WEEK20 . Surveillance swab sample collection at week 20 End of visit assessment C4591001TVDNSSWAB_WEEK22 . Surveillance swab sample collection at week 22 End of visit assessment C4591001TVDOSSWAB_WEEK24 . Surveillance swab sample collection at week 13 End of visit assessment C4591001TVDOSSWAB_WEEK26 . Surveillance swab sample collection at week 14 End of visit assessment C4591001TVDOSSWAB_WEEK28 . Surveillance swab sample collection at week 15 End of visit assessment C4591001TVDKSCR . Informed consent End of screening visit assessment C4591001TVDLV1_DAY1_VAX1_S A Day 1 End of visit 1 assessment C4591001TVDMV2_DAY2_POSTVAX1_S A 1 to 3 days after visit 1 End of visit 2 assessment C4591001TVDNV3_WEEK1_POSTVAX1_S Ap 6 to 8 days after visit 1 End of visit 3 assessment C4591001TVDOV4_WEEK3_VAX2_S B 19 to 23 days after visit 1 End of visit 4 assessment C4591001TVDPV5_WEEK1_POSTVAX2_S B 6 to 8 days after visit 4 End of visit 5 assessment C4591001TVDQV6_WEEK2_POSTVAX2_S B# 12 to 16 days after visit 4 End of visit 6 assessment C4591001TVDRV7_MONTH1_S B4 28 to 35 days after visit 4 End of visit 7 assessment C4591001TVDSV8_MONTH6_S B 154 to 168 days after visit 4 End of visit 8 assessment C4591001TVDTV9_MONTH12_S C 350 to 378 days after visit 4 End of visit 9 assessment C4591001TVDUV10_MONTH24_S C. 714 to 742 days after visit 4 End of visit 10 assessment C4591001TVD]V1_DAY1_VAX1_L A Day 1 End of visit 1 assessment C4591001TVD^V2_VAX2_L B 19 to 23 days after visit 1 or 56 to 70 days after visit 1 End of visit 2 assessment C4591001TVD_V3_MONTH1_POSTVAX2_L B3 28 to 35 days after visit 2 End of visit 3 assessment C4591001TVD`V4_MONTH6_L B 154 to 168 days after visit 2 End of visit 4 assessment C4591001TVDaV5_MONTH12_L C0 350 to 378 days after visit 2 End of visit 5 assessment C4591001TVDbV6_MONTH24_L C- 714 to 742 days after visit 2 End of visit 6 assessment C4591001TVDcPOT_COVID_ILL . Optimally within 3 days after potential COVID-19 illness onsetEnd of illness telehealth visit assessment C4591001TVDdPOT_COVID_CONVA . 28 to 35 days after potential COVID-19 illness visit End of convalescent visit assessment C4591001TVDhEnd of Treatment . Start of end of treatment visit C4591001TVDiFollow-Up . First day of follow-up visit C4591001TVFȎV4_WEEK3_VAX2_S_R . NA End of visit 4_R assessment C4591001TVFȏV5_WEEK1_POSTVAX2_S_R. 6 to 8 days after visit 4_R End of visit 5_R assessment C4591001TVFȐV6_WEEK2_POSTVAX2_S_R. 12 to 16 days after visit 4_R End of visit 6_R assessment C4591001TVFȑV7_MONTH1_S_R . 28 to 35 days after visit 4_R End of visit 7_R assessment C4591001TVG0REVAX_CONTACT . Start of contact End of repeat screening visit assessment C4591001TVG0V101_VAX3 . Open label vaccination 1 End of visit assessment C4591001TVG0 V102_VAX4 . Open label vaccination 2 End of visit assessment C4591001TVG00V103_MONTH1 . 28 to 35 Days after visit 102 End of visit assessment C4591001TVG0@V104_MONTH6 . 175 to 189 days after visit 102 End of visit assessment C4591001TVG0PV105_MONTH18 . 532 to 560 days after visit 102 End of visit assessment C4591001TVG6XV201_SURVEIL_CONSENT . Infection Surveillance Consent End of visit assessment